Literature DB >> 31688577

Lower circulating irisin in middle-aged and older adults with osteoporosis: a systematic review and meta-analysis.

Kunyan Zhou1,2,3, Xiaoyong Qiao1,2,3, Yitong Cai4, Ailin Li5, Dan Shan1,2,3.   

Abstract

OBJECTIVE: Osteoporosis has imposed a heavy socioeconomic burden worldwide, especially in postmenopausal women. As a newly found protein, irisin has an important physiological role in bone metabolism. This meta-analysis intends to identify the association between circulating irisin levels and osteoporosis.
METHODS: This meta-analysis was conducted following the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guideline. A comprehensive search of five databases was performed from inception to January 2019. Studies with original date on middle-aged and older participants were included. Data were analyzed according to study characteristics and heterogeneity between studies. The quality of each study and the presence of publication bias were assessed by Newcastle-Ottawa score (NOS) and normal quantile plot.
RESULTS: Seven studies, with a total of 1,018 participants, conducted in four countries, were included. Six of them were identified as high-quality research. Five studies included postmenopausal women, and two studies included both men and women. Possible publication bias was found in the analysis of irisin and osteoporosis. Pooled analysis indicated decreased irisin levels in osteoporotic participants (mean difference -87.91, 95% CI, -92.56 to -83.25). Subgroup analysis revealed an even lower level of irisin in postmenopausal women and in participants with a history of fractures. Analysis on associations between irisin and femoral neck or lumbar spine bone mineral density showed a weak positive correlation.
CONCLUSIONS: The findings of this analysis suggested that circulating irisin levels were decreased in middle-aged and older participants with osteoporosis. Irisin was positively correlated with bone mineral density.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31688577     DOI: 10.1097/GME.0000000000001388

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  11 in total

1.  Irisin improves delayed bone repair in diabetic female mice.

Authors:  Yuko Kinoshita; Yoshimasa Takafuji; Katsumi Okumoto; Yuto Takada; Hiroki Ehara; Yuya Mizukami; Naoyuki Kawao; Jun-Ichiro Jo; Yasuhiko Tabata; Hiroshi Kaji
Journal:  J Bone Miner Metab       Date:  2022-08-04       Impact factor: 2.976

Review 2.  Physical Activity and Post-Transcriptional Regulation of Aging Decay: Modulation of Pathways in Postmenopausal Osteoporosis.

Authors:  Federica Vita; Sebastiano Gangemi; Giovanni Pioggia; Fabio Trimarchi; Debora Di Mauro
Journal:  Medicina (Kaunas)       Date:  2022-06-06       Impact factor: 2.948

Review 3.  A Bibliometric Analysis of the Literature on Irisin from 2012-2021.

Authors:  Jiangshan Liu; Bote Qi; Lin Gan; Yanli Shen; Yu Zou
Journal:  Int J Environ Res Public Health       Date:  2022-05-18       Impact factor: 4.614

4.  Irisin deficiency disturbs bone metabolism.

Authors:  Xiaofang Zhu; Xiangfen Li; Xiaoxuan Wang; Ting Chen; Fengjuan Tao; Chuanju Liu; Qisheng Tu; Guofang Shen; Jake J Chen
Journal:  J Cell Physiol       Date:  2020-06-22       Impact factor: 6.384

5.  In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alteration.

Authors:  Laurent Maïmoun; Denis Mariano-Goulart; Helena Huguet; Eric Renard; Patrick Lefebvre; Marie-Christine Picot; Anne-Marie Dupuy; Jean-Paul Cristol; Philippe Courtet; Vincent Boudousq; Antoine Avignon; Sébastien Guillaume; Ariane Sultan
Journal:  Endocr Connect       Date:  2022-05-10       Impact factor: 3.221

6.  Modification of Muscle-Related Hormones in Women with Obesity: Potential Impact on Bone Metabolism.

Authors:  Laurent Maïmoun; Thibault Mura; Vincent Attalin; Anne Marie Dupuy; Jean-Paul Cristol; Antoine Avignon; Denis Mariano-Goulart; Ariane Sultan
Journal:  J Clin Med       Date:  2020-04-17       Impact factor: 4.241

7.  Serum Irisin Level Is Positively Associated with Bone Mineral Density in Patients on Maintenance Hemodialysis.

Authors:  Chia-Wen Lu; Chih-Hsien Wang; Yu-Li Lin; Chiu-Huang Kuo; Yu-Hsien Lai; Bang-Gee Hsu; Jen-Pi Tsai
Journal:  Int J Endocrinol       Date:  2021-01-25       Impact factor: 2.803

8.  The Association of Serum Irisin with Bone Mineral Density and Turnover Markers in New-Onset Type 2 Diabetic Patients.

Authors:  Xiujing Wang; Tianxiao Hu; Yun Ruan; Jiaqi Yao; Huiling Shen; Yao Xu; Bojing Zheng; Zhengying Zhang; Jing Wang; Qingying Tan
Journal:  Int J Endocrinol       Date:  2022-02-28       Impact factor: 2.803

Review 9.  Progress and Challenges in the Biology of FNDC5 and Irisin.

Authors:  Steffen Maak; Frode Norheim; Christian A Drevon; Harold P Erickson
Journal:  Endocr Rev       Date:  2021-07-16       Impact factor: 19.871

10.  Circulating Irisin Level and Thyroid Dysfunction: A Systematic Review and Meta-Analysis.

Authors:  Dan Shan; Li Zou; Xijiao Liu; Yitong Cai; Ruihong Dong; Yayi Hu
Journal:  Biomed Res Int       Date:  2020-10-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.